Pentoxifylline: Brief Review and Rationale for Its Possible Use in the Treatment of Autism

Tilg H. , Eibl B. , Pichl M. , et al: Immune response modulation by pentoxifylline in vitro. Transplantation 1993;56:196-201.

Hawkins ES , Ribiero HA : Pentoxifylline review. JAm Podiatr Med Assoc 1987;77:645-647.

Cardinali DP : Effect of pentoxifylline and theophylline on neurotransmitter uptake and release by synaptosome-rich homogenates of the rat hypothalamus. Neuropharmacology 1977 ; 16:785-790.

Kitatani T. , Watanabe T. , Shibuya T. : Different effects of methylxanthines on central serotonergic postsynaptic neurons in a mouse behavioral model. Pharmacol Biochem Behav 1993;44: 457-461.

Fiers W , Buurman WA (eds): Tumor Necrosis Factor: Molecular and Cellular Biology and Clinical Relevance. Basel, Karger, 1993.

Spriggs D. , Deutsch S. , Kufe DW : Genomic structure, induction and production of tumor necrosis factor-α , in Vilcek J , Aggarwal BB (eds): TNF: Structure, Function and Mechanisms of Action. New York, Mercel-Dekker, 1991, pp 3-34.

McCann SM , Rettori V. , Milenkovic L. , et al: Role of monokines in control of anterior pituitary hormone release, in Porter JC , Jezova D (eds): Circulating Regulatory Factors and Neuroendocrine Function. New York , Plenum, 1990, pp 315-329.

Selman K. , Raine CS : Tumour necrosis factor mediates myelin and oligodendrocyte damage in vitro . Ann Neurol 1988;23:339-346.

Brosnan CF , Selmaj K. , Raines CS : Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 1988;18:87-94.

Baker D. , O'Neill JK , Turk JL : Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell Immunol 1991 ;134:505-510.

Mintz M. , Rapaport R. , Oleske JM , et al: Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am J Dis Child 1989;143:771-774.

Ruddle NH , Bergman CM , McGrath KM , et al: An antibody to lymphotoxin and tumour necrosis factor prevents transfer of experimental allergic encephalitis. J Exp Med 1990; 172:1193-2000.

Weinberg JB , Mason SN , Wortham TS : Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: Dissociation of acivicininduced TNF-alpha and IL-1 beta mRNA expression from acivicininduced monocytoid differentiation . Blood 1992;79:3337-3343.

Hans J. , Thompson P. , Buetler B. : Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990;172:391-394.

Schandene L. , Vandenbussche P. , Crusiaux A. , et al: Differential effects of pentoxifylline on the production of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) by monocytes and T cells. Immunology 1992;76:30-34.

Rott O. , Cash E. , Fleische B. : Phosphodiesterase inhibitor, pentoxifylline, a selective suppressor T helper typel—but not type 2—associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats . Eur J Immunol 1993;23:745-751.

Takahashi GW , Montgomery RB , Stahl WL , et al: Pentoxifylline inhibits tumor necrosis factor-alpha-mediated cytotoxicity and cytostasis in L929 murine fibrosarcoma cells. Int J Immunopharmacol 1994;16:723-736.

Berman B. , Wietzerbin J. , Sanceau J. , et al: Pentoxifylline inhibits certain constitutive and tumor necrosis factor-alpha-induced activities of human normal dermal fibroblasts. J Invest Dermatol 1992;98:706-712.

Okuda Y. , Sakoda S. , Yanagihara T. : Modulation of cytokine production by pentoxifylline in experimental allergic encephalitis, submitted.

Nataf S. , Louboutin JP , Chabannes D. , et al: Pentoxifylline inhibits experimental allergic encephalomyelitis . Acta Neurol Scand 1993;88:97-99.

Bianco JA , Appelbaum FR , Nemunaitis J. , et al: Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood 1991;78:1205-1211.

Dezube BJ , Pardee AB , Chapman B. , et al: Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trial Group. J Acquired Immune Defic Syndr 1993;6:787-794.

Dezube BJ , Sherman ML , Friedovich-Keil JL , et al: Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients. A pilot study. Cancer Immunol Immunother 1993; 36:57-60.

Leimenstoll G. , Zabel P. , Schroeder P. , et al: Suppression of OKT-3-induced tumor necrosis alpha formation by pentoxifylline in renal transplant recipients . Transplant Proc 1993 ;25:561-563.

Gibson RL , Redding GJ , Henderson WR , Truog WE : Group B streptococcus induces tumor necrosis factor in neonatal piglets. Effect of the tumor necrosis factor inhibitor pentoxifylline on hemodynamics and gas exchange. Am Rev Respir Dis 1991; 143:598-604.

Matuschak GM , Lamprech KE , Lechner AJ : Pentoxifylline inhibits tumor necrosis factor production in septic shock. J Interferon Res 1994;14:293-295.

Stellin SP , Waxman K. : Current and potential therapeutic effects of pentoxifylline. Compr Ther 1989;15:11-13.

Olsson RA , Pearson JD : Cardiovascular purinoreceptors. Physiol Rev 1990;70:761-845.

Tanake Y. , Sakurai M. , Goto M. , Hayashi S. : Effect of xanthine derivatives on hippocampal long-term potentiation . Brain Res 1990; 522:63-68.

Anderson GM , Freedman DX , Cohen DJ , et al: Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 1987;28:885-900.

Todd RD , Ciaranello RD : Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proc Natl Acad Sci USA 1985;82:612-616.

Hoshino Y. , Tachibana JR , Watanabe M. , et al: Serotonin metabolism and hypothalamic-pituitary function in children with infantile autism and minimal brain dysfunction. Jpn J Psychiatry Neurol 1984;26:937-945.

McBride PA , Anderson GM , Hertzig ME , et al: Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. Arch Gen Psychiatry 1989;46:213-221.

McDougle CJ , Naylor ST , Goodman WK , et al: Acute tryptophan depletion in autistic disorder: A controlled case study. Biol Psychiatry 1993;33:547-550.

McDougle CJ , Price LH , Volkmar FR : Recent advances in the pharmacotherapy of autism and related conditioins. Psychiatr Pervasive Dev Disord 1994;3:71-89.

Gillberg C , Coleman M (eds): The Biology of Autistic Syndrome, London, Mac Keith Press, 1992, pp 149-161.

Mountz JM , Tolbert LC , Lill DW , et al: Functional deficits in autistic disorder: Characterization by technetium-99m-HMPAO and SPECT. J Nucl Med 1995;38:1156-1162.

Dominguez D. , de Cayaffa CL , Gomensoro J. , Aparicio NJ : Modification of psychometric, practical and intellectual parameters in patients with diffuse cerebrovascular insufficiency during prolonged treatment with pentoxifylline: A double-blind, placebo control trial. Pharmatherapeutica 1977;1:498-506.

Kanner L. : Autistic disturbances of afffective contact. J Nerv Child 1943;2:217-250.

Sogame S. : Clinical experiences with the administration of pentoxifylline against autism and behavior abnormalities. Jpn J Child Psych 1978;19:137-144.

Nakane A. : Effect of pentoxifylline in autistic children. Tokyoto Eisei Gakkashi 1980;65:104-105.

Shimoide M. : Effect of pentoxifylline (Trental) on infantile autism. Clin Exp Med 1981;58:285-288.

Turek S. : Treatment of psychotic and autistic children with pentoxifylline. ASANA 1981;1:51-60.

Seasick M. , Nakazima K. , Sugiyama A. , et al: On the effects of pentoxifylline upon the EEG activity of early infantile autism, abstract. Brain Dev 1984 ;6:156.